156 related articles for article (PubMed ID: 29889714)
1. RETINA.
Retina; 2018 Jun; 38 Suppl 3():1-13. PubMed ID: 29889714
[No Abstract] [Full Text] [Related]
2. The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience.
Higham A; Jacob S; Cox M; Baker C; Al-Husainy S; Sivaraj R; Gibson JM
Acta Ophthalmol; 2016 Nov; 94(7):e674-e675. PubMed ID: 27010078
[No Abstract] [Full Text] [Related]
3. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.
Matonti F; Meyer F; Guigou S; Barthelemy T; Dumas S; Gobert F; Hajjar C; Merite PY; Parrat E; Rouhette H; Pommier S
Acta Ophthalmol; 2013 Nov; 91(7):e584-6. PubMed ID: 23764276
[No Abstract] [Full Text] [Related]
4. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
[No Abstract] [Full Text] [Related]
5. Dexamethasone intravitreal implants for retinal vein occlusion in a clinical setting.
Krivosic V; Bheekee A; Michée S; Delyfer MN; Tadayoni R; Korobelnik JF
Acta Ophthalmol; 2014 Nov; 92(7):e584-5. PubMed ID: 24629069
[No Abstract] [Full Text] [Related]
6. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
7. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
8. Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion.
Veritti D; Macor S; Lanzetta P
Ophthalmologica; 2014; 232(3):144-8. PubMed ID: 25300393
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).
Capone A; Singer MA; Dodwell DG; Dreyer RF; Oh KT; Roth DB; Walt JG; Scott LC; Hollander DA
Retina; 2014 Feb; 34(2):342-51. PubMed ID: 23846381
[TBL] [Abstract][Full Text] [Related]
10. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Călugăru D; Călugăru M
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):211-212. PubMed ID: 27752778
[No Abstract] [Full Text] [Related]
11. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
[TBL] [Abstract][Full Text] [Related]
12. Accidental injection of dexamethasone intravitreal implant in the crystalline lens.
Fasce F; Battaglia Parodi M; Knutsson KA; Spinelli A; Mauceri P; Bolognesi G; Bandello F
Acta Ophthalmol; 2014 Jun; 92(4):e330-1. PubMed ID: 24373603
[No Abstract] [Full Text] [Related]
13. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
15. Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting.
Parodi MB; Iacono P; Cascavilla M; Zucchiatti I; Bandello F
Acta Ophthalmol; 2012 Jun; 90(4):e322-3. PubMed ID: 21939501
[No Abstract] [Full Text] [Related]
16. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
Udaondo P; Garcia-Delpech S; Salom D; Garcia-Pous M; Díaz-Llopis M
Am J Ophthalmol; 2011 Aug; 152(2):326-7; author reply 327-8. PubMed ID: 21784203
[No Abstract] [Full Text] [Related]
17. Re: Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Yolcu Ü; Tas A; Ilhan A; Altun S; Gundogan FC
Retina; 2015 Mar; 35(3):e24-5. PubMed ID: 25699509
[No Abstract] [Full Text] [Related]
18. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
Bakri SJ; Omar AF
J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
[TBL] [Abstract][Full Text] [Related]
19. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
